Moreover, the fact that Ar-1 also exhibits a broad spectrum of activities against Gram-positive and Gram-negative bacterial as well as fungal pathogens [33], such as Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans, respectively, either alone or in combination with classical antibiotics as its synergistic activity has also been demonstrated [87], opens new perspectives for CF patients. The gene discussed is TCF20; the disease is cystic fibrosis.